… This nonsignificant 5% reduction in the risk of pneumonia (rate ratio [RR… risk reduction
associated with ICS withdrawal in COPD. In this article, we assess the effect of ICS discontinuation …

… We sought to estimate the risk of asthma exacerbation in patients who stop low-dose inhaled
corticosteroids (ICSs) compared with those who continue ICSs in randomized controlled …

… The aim of this double-blind single center study (the COPE study) was to investigate the
effect of discontinuation of the inhaled corticosteroid fluticasone propionate (FP) on …

… This was an observational comparative effectiveness study aimed to evaluate the effect of
inhaled corticosteroid (ICS) cessation versus continuation of triple therapy in COPD patients. …

… Recently a small prospective, randomised, placebo-controlled, crossover trial evaluated
the effect of inhaled corticosteroids withdrawal on lung function, exercise capacity, respiratory …

… 3 years, with a 20% risk reduction over the first month [69]. Of note, patients … discontinued
fluticasone showed greater reductions in severe pneumonia risk than those who discontinued …

… withdrawal of inhaled corticosteroid (ICS) in chronic obstructive pulmonary disease (COPD).
We performed a quantitative synthesis in order to assess real impact of ICS discontinuation …

… these studies [56] suggested that inhaled corticosteroids reduced the decline of lung function.
A … the effect of 6 months discontinuation of inhaled corticosteroids in COPD patients after 4 …

… Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease: the COPE study. Am J Respir Crit Care Med. 2002;166:1358–1363. …

… -based guidelines for the withdrawal of inhaled corticosteroids (ICS) in … We assessed the
effect of ICS discontinuation on the … Subjects who discontinued ICS were matched 1:1 on time-…